NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News $20.43 -0.46 (-2.20%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$20.43 0.00 (0.00%) As of 05/21/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBBQ alerts:Sign Up Key Stats Today's Range$20.39▼$20.7150-Day Range$18.67▼$22.5652-Week Range$17.84▼$24.84Volume2,108 shsAverage Volume17,119 shsMarket Capitalization$36.98 millionAssets Under Management$36.53 millionDividend Yield1.17%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF OverviewThe Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More… Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.57%0.57%0.54%0.53%Other Expenses0.00%0.30%0.48%0.42%0.51%Total Expense0.19%0.70%0.72%0.68%0.71%Fee Waiver0.00%-0.45%-0.49%-0.29%-0.54%Net Expense0.19%0.61%0.63%0.62%0.60% Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBBQ ETF News HeadlinesInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.04021March 24, 2025 | msn.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0619December 23, 2024 | msn.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 22, 2025 | Porter & Company (Ad)Invesco Launches New ETFs Targeting AI, Cybersecurity, And Defense. Here's How Some Of Their Peers Have Performed In The Past YearNovember 7, 2024 | msn.comIBBQ Invesco Nasdaq Biotechnology ETFOctober 21, 2024 | seekingalpha.comUpstream Bio valued at $1.1 bln as shares jump in Nasdaq debutOctober 11, 2024 | reuters.comSee More Headlines IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed this year? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.52 at the start of the year. Since then, IBBQ shares have decreased by 5.1% and is now trading at $20.43. View the best growth stocks for 2025 here. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Top institutional investors of Invesco Nasdaq Biotechnology ETF include Partners Capital Investment Group LLP (1.43%), Breakwater Capital Group (1.23%) and CreativeOne Wealth LLC (0.58%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Nasdaq Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Nasdaq Biotechnology ETF investors own include Vanguard Total Stock Market ETF (VTI), Verizon Communications (VZ), CrowdStrike (CRWD), DocuSign (DOCU), Meta Platforms (META), NVIDIA (NVDA) and Shopify (SHOP). Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings265 Fund Statistics Assets Under Management$36.53 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Options OptionableN/A Short Interest900 shs Miscellaneous Outstanding Shares1,810,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Top 10 IBBQ HoldingsVertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 9.15%Amgen (NASDAQ:AMGN)Holding Weight: 8.11%Gilead Sciences (NASDAQ:GILD)Holding Weight: 8.02%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 7.18%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.49%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.61%argenx (NASDAQ:ARGX)Holding Weight: 2.18%Biogen (NASDAQ:BIIB)Holding Weight: 1.93%Summit Therapeutics (NASDAQ:SMMT)Holding Weight: 1.92%Sanofi (NASDAQ:SNY)Holding Weight: 1.67%Full Holdings DetailsIBBQ Sector ExposureIBBQ Industry Exposure This page (NASDAQ:IBBQ) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.